We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Prescription topical. Bimatoprost 0.03% is applied once daily as a thin line to the skin of the UPPER eyelid margin at the lash base (not to the lower lid, and avoid getting it in the eye), using a fresh applicator per eye. Continuous use is needed to maintain results. Use under a clinician, especially if you have glaucoma or take prostaglandin eye drops. There is no oral or systemic use. This library does not provide an ingestion protocol.
Evening
Bimatoprost 0.03% solution (Latisse) with single-use applicators, under a clinician
Approved (Vyleesi): 1.75 mg subcutaneous, self-injected on-demand ~45 min before anticipated sexual activity; max 1 dose/24 h and 8 doses/month
Any time
Subcutaneous auto-injector (Vyleesi)
Throughout
8-16 weeks
2-6 months after stopping
On-demand (per dose); endpoints assessed over 24 weeks
Throughout
Within hours of dosing
Like what you see? Add these to your stack.
See how they work together through biological pathways.
Build Your StackWant to compare more supplements?